Attention-deficit/hyperactivity disorder (ADHD) appears to be somehow linked to risk of dementia and Alzheimer’s disease, a new multigenerational study has found.
Parents and grandparents of people with ADHD have a higher risk of Alzheimer’s and dementia than people with no ADHD in their family, Swedish researchers said.
Specifically, parents of an ADHD child have a 34% higher risk of dementia and 55% higher risk of Alzheimer’s, the results showed. Grandparents have about an 11% increased risk of either condition. [Read more…] about Study finds ADHD is associated with dementia
Using specific frequencies of flashing lights and sounds to stimulate the brain’s electrical activity, Cognito Therapeutics believes it can help treat Alzheimer’s disease by energizing neurons and reactivating the immune system.
Quick heads-up about a great event next month for those based in the San Francisco Bay Area.
- When: Tuesday, September 17, 2019 / 8:30 AM – 6:00 PM PDT
- Where: Pauley Ballroom, UC Berkeley
- What: 2019 UC Berkeley Aging Research & Technology Summit: Disrupting Neurodegenerative Diseases
Alzheimer’s and neurodegenerative diseases are [Read more…] about September 17th @ UC Berkeley: Disrupting neurodegenerative diseases
Description: Quickly developing neurotechnologies will have an impact on entire industries, governments, and societies in the future. The Global Future Council on Neurotechnologies will explore these technological developments and their ethical implications for society. [Read more…] about The World Economic Forum hosts Global Future Council on Neurotechnologies in Dubai (November 10–12th)
“Advanced Brain Monitoring Inc was named the “Most Innovative Medical Device Company” by Global Health and Pharma at its 2016 Healthcare and Pharmaceutical awards. “This award recognizes our company’s successes in developing technologies which enable clinicians and clinical trial sponsors to profile brain health through the analysis of the brain’s electrical activity (EEG) during sleep and wake,” says Chris Berka, Advanced Brain Monitoring CEO…The company was recently awarded a $1.5 mm grant from National Institute of Health to expand its database of awake and sleep EEG in patients with neurodegenerative diseases. “The envisioned future is for routine brain health assessments during sleep and waking to be conducted in a manner similar to a mammogram or colonoscopy,” says Berka. “Ultimately, early detection will increase the likelihood that an intervention can be matched to the patient based on the presence of brain biomarkers and administered prior to the onset of cognitive decline.”
To learn more:
The 2011 SharpBrains Summit gathered more than 260 research and industry leaders in 16 countries for 3 days to discuss the changing landscape. Held online, participants from all over the globe attended to hear more than 40 thought leaders, scientists, entrepreneurs and policy makers outline the evolving marketplace. Discussion moved from cognitive fitness to neuroplasticity, across regulatory and policy trends, and new product launches by new and established players What did we take home from the SharpBrains Summit? Was it novel consumer insights arising from a new retail landscape? What of policy initiatives from innovation clusters around the globe? Do you see a future populated by neuroscience toolkits, driven by the inexorable demographic changes set to occur in the coming decades? Or was it a look “under the hood” of technology platforms developed by category leaders that sharpened our insight? Here are 10 emerging themes:
1. The Need for Standardization of methodologies
A profusion of cognitive and emotional health tests, batteries and new technologies are crowding the research environment. The NIH toolbox for the assessment of a broad range of cognitive domains [Read more…] about Lessons from the SharpBrains Summit: Status Quo Not an Option